The company is reiterating its plans to initiate a $150M share repurchase in 2023. The company may repurchase shares at its discretion, subject to applicable regulatory and other legal requirements. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions, regulatory requirements, and other corporate considerations, and could be suspended or discontinued at any time as determined by management. Commencement of share repurchases is expected to occur in early 2023, and the Company may utilize various methods to make the repurchases.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on IART:
- Integra LifeSciences Reports Select Preliminary Fourth Quarter and Full-Year 2022 Financials
- Integra LifeSciences to Present at 41st Annual J.P. Morgan Healthcare Conference
- Integra LifeSciences price target raised to $60 from $50 at Citi
- Integra LifeSciences Completes the Acquisition of Surgical Innovation Associates
- Integra LifeSciences plans $150M share repurchase